Providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities, SMi presents the 20th annual Superbugs & Superdrugs conference which will return to Central London on 19th and 20th March 2018.
The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders from Nemesis Bioscience, ABAC Therapeutics, Oppilotech, Gladius Pharmaceuticals, Pew Charitable Trusts, Blueberry Therapeutics, UNT Health Science Center, ContraFect, SCYNEXIS; and government bodies such as MHRA and DNDi. The full speaker line-up and conference agenda is available at http://www.superbugssuperdrugs.com/bentham
Relevant Journal: Anti-Infective Agents
Relevant EBook: Frontiers in Anti-Infective Drug Discovery